Literature DB >> 5322369

Immunological studies in ulcerative colitis. II. "Colon" antigen and human blood group A- and H-like antigens in germfree rats.

S Hammarström, R Lagercrantz, P Perlmann, B E Gustafsson.   

Abstract

Sera from patients with ulcerative colitis contain antibodies which hemagglutinate sheep red cells, sensitized with phenol-water extracts from. colon, cecum, or feces of germfree rats. Minor concentrations of such antibodies are also present in a certain fraction of normal human sera. Hemagglutination and hemagglutination inhibition experiments with human erythrocytes and with the rat extracts showed that the latter contained an antigen similar to human blood group A antigen. In contrast, a blood group B-like antigen could not be detected in these extracts. However, experiments with eel serum indicated that these extracts also contained an antigen similar to the H antigen of the human ABO system. Absorption of ulcerative colitis sera with human A(1) erythrocytes but not that with B or O erythrocytes gave, in a few cases, a slight reduction of the hemagglutinating titers against rat cecum-sensitized sheep erythrocytes. In contrast, this treatment considerably reduced such titers when found in sera from healthy persons or from patients with unrelated diseases. It could be concluded that the rat extracts also contained a "colon" antigen, detected with antibodies, present at elevated titers, in the sera of ulcerative colitis patients, but not in those of the controls. This colon antigen is immunologically distinct from the blood group antigens studied. Hemagglutination inhibition experiments indicated that A, H and colon antigen were widely distributed throughout the gastrointestinal tract of the germfree rats. The colon antigen was found to be enriched in the extracts from colon, cecum, and feces. Fluorescent antibody staining provided evidence that both the colon antigen and the A antigen were present in similar sites of the colon and cecum mucosa, particularly in goblet cells of the crypts, and in the mucus.

Entities:  

Mesh:

Substances:

Year:  1965        PMID: 5322369      PMCID: PMC2138100          DOI: 10.1084/jem.122.6.1075

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  8 in total

1.  Incidence of haemagglutinating and complement-fixing antibodies.

Authors:  G L ASHERSON; O BROBERGER
Journal:  Br Med J       Date:  1961-05-20

2.  [DEMONSTRATION BY IMMUNOFLUORESCENCE OF A TISSUE ANTIGEN RELATED TO HUMAN. AN ERYTHROCYTIC AGGLUTINOGEN IN THE COLIC GLANDS OF VARIOUS MAMMALS].

Authors:  B HALPERN; A ZWEIBAUM; P OUDEA; C VEYRE
Journal:  C R Hebd Seances Acad Sci       Date:  1965-03-15

3.  Auto-antibodies against antigen derived from colon in the microsomes of regional colonic lymph glands in human ulcerative colitis.

Authors:  P PERLMANN; O BROBERGER
Journal:  Nature       Date:  1960-11-26       Impact factor: 49.962

4.  Ultra-rapid fluorescent labelling of proteins.

Authors:  H RINDERKNECHT
Journal:  Nature       Date:  1962-01-13       Impact factor: 49.962

5.  Autoantibodies in human ulcerative colitis.

Authors:  O BROBERGER; P PERLMANN
Journal:  J Exp Med       Date:  1959-11-01       Impact factor: 14.307

6.  MUCUS IN INTESTINAL CONTENTS OF GERMFREE RATS.

Authors:  G LINDSTEDT; S LINDSTEDT; B E GUSTAFSSON
Journal:  J Exp Med       Date:  1965-02-01       Impact factor: 14.307

7.  Localization of antigen in tissue cells; improvements in a method for the detection of antigen by means of fluorescent antibody.

Authors:  A H COONS; M H KAPLAN
Journal:  J Exp Med       Date:  1950-01-01       Impact factor: 14.307

8.  Demonstration of an epithelial antigen in colon by means of fluorescent antibodies from children with ulcerative colitis.

Authors:  O BROBERGER; P PERLMANN
Journal:  J Exp Med       Date:  1962-01-01       Impact factor: 14.307

  8 in total
  14 in total

1.  In vitro anticolon antibody production by mucosal or peripheral blood lymphocytes from patients with ulcerative colitis.

Authors:  T Hibi; M Ohara; K Toda; A Hara; H Ogata; Y Iwao; N Watanabe; M Watanabe; Y Hamada; K Kobayashi
Journal:  Gut       Date:  1990-12       Impact factor: 23.059

2.  Autoantibodies in ulcerative colitis.

Authors:  A R McGiven; T Ghose; R C Nairn
Journal:  Br Med J       Date:  1967-04-01

3.  The problem of chronic inflammatory bowel disease.

Authors:  D W Watson
Journal:  Calif Med       Date:  1972-07

4.  Immunological studies in ulcerative colitis. 3. Incidence of antibodies to colon-antigen in ulcerative colitis and other gastro-intestinal diseases.

Authors:  R Lagercrantz; S Hammarström; P Perlmann; B E Gustafsson
Journal:  Clin Exp Immunol       Date:  1966-07       Impact factor: 4.330

5.  Some physico-chemical and serological properties of isolated protein components of red cell membranes.

Authors:  M D Poulik; P K Lauf
Journal:  Clin Exp Immunol       Date:  1969-01       Impact factor: 4.330

Review 6.  The immunologic basis of inflammatory bowel disease.

Authors:  W Strober; S P James
Journal:  J Clin Immunol       Date:  1986-11       Impact factor: 8.317

Review 7.  Idiopathic Inflammation Bowel Disease: is there a role for immunological mechanisms in etiopathogenesis?

Authors:  R G Shorter
Journal:  Gastroenterol Jpn       Date:  1982-10

8.  Immunological studies in ulcerative colitis. VII. Anti-colon antibodies of different immunoglobulin classes.

Authors:  J Zeromski; P Perlmann; R Lagercrantz; S Hammarström; B E Gustafsson
Journal:  Clin Exp Immunol       Date:  1970-10       Impact factor: 4.330

9.  Immunological studies in ulcerative colitis. VI. Light microscopic studies with peroxidase conjugated antibodies.

Authors:  J Zeromski; P Perlmann; R Lagercrantz; B E Gustafsson
Journal:  Clin Exp Immunol       Date:  1970-10       Impact factor: 4.330

10.  A study of peripheral leucocyte migration in agarose medium in inflammatory bowel disease.

Authors:  W Bartnik; E T Swarbrick; C Williams
Journal:  Gut       Date:  1974-04       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.